2019 annual financial data
Emergent BioSolutions 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was 17%.
Operating income was 114,100,000 USD and net income was 54,500,000 USD.
Operating cash flow was 188,000,000 USD.
Get free Emergent BioSolutions email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,106,000,000 USD
- Operating income
- 114,100,000 USD
- Net income
- 54,500,000 USD
- Operating cash flow
- 188,000,000 USD